Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

International Journal of Cancer

Volumn 90, Issue 4, 2000, Pages 206-223

  Roberts, Kenneth B ^a   Urdaneta, Nelson ^b,d   Vera, Raul ^d   Vera, Andres ^c,d   Gutierrez, Enrique ^b,d   Aguilar, Yadelis ^b   Ott, Sara ^b   Medina, Ivonne ^b   Sempere, Pilar ^b   Rockwell, Sara ^a   Sartorelli, Alan C ^a   Fischer, Diana B ^a   Fischer, James J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c Hospital Dr Domingo Luciani   (Venezuela)

^d La Floresta Medical Institute   (Venezuela)

Author keywords

Cervix cancer; Combined modality therapy; Mitomycin C; Radiotherapy

Indexed keywords

MITOMYCIN C;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA; PRIORITY JOURNAL; PROCTITIS; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VOMITING;

ACTUARIAL ANALYSIS; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0033852149     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000820)90:4<206::AID-IJC4>3.0.CO;2-O     Document Type: Article

References (85)

1. Global Cancer Statistics
2. Cancer Statistics 1999
3. Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H. Fletcher Guidelines: A French Cooperative Study of 1383 Cases
4. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the Uterine cervix
5. Effect of tumor size on the prognosis of Carcinoma of the uterine cervix treated with irradiation alone
6. FIGO stage IIIB squamous cell carcinoma of the uterine cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy
7. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariate analysis of the effect of age, stage, histology, and blood counts on survival
8. Analysis of results of radiation therapy for Stage II carcinoma of the cervix
9. Analysis of results of radiation therapy for Stage IB carcinoma of the cervix
10. Carcinoma of the cervix Stage III
11. Combined modality treatment with radiotherapy and chemotherapy
12. Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer
13. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer
14. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
15. Essai randomise de chimotherapie initiale dane 151 carcinomes du col uteria localement etendus (T2b-N1, T3b, M0)
16. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix
17. Radiotherapy and neoadjuvant chemotherapy in cervical carcinoma: A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
18. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer
19. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial
20. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy alone in patients with locally advanced cervical cancer
21. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
22. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
23. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
24. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
25. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer
26. Radiation therapy alone or combined with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix (stage IB, IIA, IIB)
27. Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix
28. Carcinoma of the intact uterine cervix, Stage IB-IIA-B, >6 cm in diameter: Irradiation alone vs. preoperative irradiation and surgery
29. Hypoxic fractions of human tumors xenografted into mice: A review
30. Tumor hypoxia: Its impact on cancer therapy
31. Oxygen tension of cervical carcinoma during the early phase of external irradiation
32. Intercapillary distance, oxygen tension and local recurrence in cervix cancer
33. NMR in Cancer. I. High resolution spectroscopy of tumors
34. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia
35. The significance of anemia in clinical radiation therapy
36. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
37. Definitive evidence for hypoxic cells influencing cure in cancer therapy
38. Carcinoma of the cervixanaemia, radiotherapy and hyperbaric oxygen
39. Hyperbaric oxygen and radiotherapy: A Medical Research Council trial in carcinoma of the cervix
40. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
41. Interrelationship of proliferation and hypoxia in carcinoma of the cervix
42. Mutagenesis induced by the tumor microenvironment
43. The role of hypoxia, p53 and apoptosis in human cervical carcinoma pathogenesis
44. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
45. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions
46. Hypoxic cervical cancers with low apoptotic index are highly aggressive
47. Neutron therapy in cervical cancer: Results of a phase III RTOG study
48. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix
49. A phase I/II study of the use of Fluosol® as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors
50. Use of hypoxia-directed drugs in the therapy of solid tumors
51. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
52. Potential bioreductive alkylating agents: I. Benzoquinone derivatives
53. Therapeutic attack of hypoxic cells of solid tumors: Presidential address
54. Mitomycin C and radiation
55. Nonsurgical management of esophageal cancer: Report of a study of combined radiotherapy and chemotherapy
56. Epidermoid anal cancer: Treatment by radiation and 5-fluorouracil with or without mitomycin C
57. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a Phase III Randomized Intergroup Study
58. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials
59. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials
60. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer
61. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix
62. Concurrent chemoirradiation in advanced cervical cancer
63. Tratamiento radiante del cancer del cuello uterino. Plan Nacional
64. Cancer del Cuello Uterino
65. Grading of chemoradiation toxicity
66. Forcing a sequential experiment to be balanced
67. Regression models and life tables
68. Cervical cancer - Staging
69. Concomitant chemoirradiation: Rationale and clinical experience in patients with solid tumors
70. Randomized clinical trial of Mitomycin C as an adjunct to radiotherapy in head and neck cancer
71. Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer
72. Preliminary results of concomitant radiotherapy in advanced cervical carcinoma
73. A phase I-II trial of multi-modality management of bulky gynecologic malignancy: Combined chemoradiosensitization and radiotherapy
74. Concomitant pelvic radiotherapy, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma
75. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: A pilot study
76. Mitomycin-C/5-FU and radiation therapy for locally advanced cervical cancer
77. Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: Preliminary results of a phase I-II study
78. Concomitant 5-fluorouracil, mitomycin C and radiotherapy for advanced gynecologic malignancies
79. Combination therapy with radiation, mitomycin C, and 5-fluorouracil in EMT6 tumors
80. Chemotherapy (CT) + Radiotherapy (RT) vs. radiotherapy alone in cervical cancer stage IIAB to IVA, a randomized study
81. Induction chemotherapy and irradiation in advanced carcinoma of the cervix
82. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix
83. Long-term follow-up of potentiation of radiotherapy by cisplatinum in advanced cervical cancer